Translational Breast Cancer Research represents a vital bridge between laboratory discoveries and clinical practice. In our pursuit to eliminate breast cancer, we must accelerate the translation of scientific innovation into treatments that reach patients worldwide. TBCR's remarkable growth, with an impact factor rising from 1.4 to 3.9, reflects the journal's commitment to publishing high-quality, clinically relevant research that advances our field. I am proud to support TBCR and look forward to its continued success in bringing transformative science to the forefront of breast cancer care.

As a member of the Editorial Board of Annals of Blood, I am honored to be part of a journal dedicated to advancing knowledge in transfusion medicine, hematology, and blood sciences through high-quality reviews and evidence-based research. I encourage our readers, authors, and reviewers to remain actively engaged in this shared mission, as their contributions are essential to maintaining the journal’s excellence, broadening its impact, and advancing the dissemination of scientific knowledge. My best wishes to the editorial team for continued success, international recognition, and sustained growth as a leading forum for scientific exchange that benefits the global community.

I am pleased to serve as an Associate Editor-in-Chief of the Annals of Blood. Under the leadership of Drs. Yongshui Fu and Huaqin Liang, the Journal has grown to become recognized as a principal international publication in the fields of transfusion medicine and hematology. It has emerged as an increasingly important presence in these fields. Its growing influence as a resource for the publication of current research and clinical investigations is reflected by its increasing Impact Factor. It has also served as a publication for important, comprehensive, and useful reviews and editorials. The Annals has grown to become a leading scholarly and educational resource.

Welcome to the Journal of Oral and Maxillofacial Anesthesia (JOMA).

It is with my heartfelt congratulations to mark JOMA's significant milestone, as JOMA has achieved the First Impact Factor of 0.9 and a CiteScore of 0.7.

JOMA is a uniquely designed journal covering a broad range of topics related to oral and maxillofacial anesthesia, including basic science and clinical advances in the field. The emphasis on evidence-based clinical outcomes is a prominent and important aspect of the journal. The editorial teams, reviewers, contributors, and the editorial board members are leaders in their respective fields.

JOMA will provide an opportunity for readers to enrich their knowledge and to be part of a unique, comprehensive, and rewarding educational journal. JOMA reflects the concept of applying basic biological science, pharmacologic therapies, tissue engineering, and clinical sciences to develop and apply innovative techniques in oral and maxillofacial anesthesia. Most importantly, outcomes are based on valid, hypothesis-driven, analytic clinical studies. JOMA is committed to helping its readers and clinicians enhance the quality of anesthesia care provided to their patients.

Congratulations, and many more years of excellence and success!

Congratulations to Pediatric Medicine on this important achievement. It has been a pleasure to contribute to a journal dedicated to improving child health through scientific excellence and international collaboration.

From my perspective as a researcher in developmental neuroscience and neonatology, I hope the journal will continue to highlight innovative studies that integrate molecular biology, genomics, and clinical research to better understand pediatric diseases, particularly neurodevelopmental disorders. Promoting interdisciplinary collaboration and translational discoveries will help accelerate the development of effective diagnostics and therapies for children. I wish Pediatric Medicine continued growth and even greater impact in the years ahead.

Congratulations to JOMA on achieving its first-ever impact factor of 0.9! This milestone is a testament to the dedication of the editorial team, reviewers, and authors who have helped shape the journal into a growing voice within oral and maxillofacial surgery/anesthesia. Wishing JOMA continued growth and success in the years ahead!